Login

Christopher U. Missling Ph.D. , CEO, Anavex Life Sciences Corp 00:00:00

Share On Facebook Share On Twitter

CEO Webinar Series Anavex Life Sciences

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Aims to democratize access to entrepreneurship by bridging the gap between untapped founders|Austin Clements,Managing Partner,Slauson & Co
00:10:00
Vendetta Mining Presentation Highlights
00:00:00
Stephen M. Ansell, M.D., Ph.D. / Ask Mayo Clinic: Lymphoma
00:10:00
Startup Success in Hard Times|Amit Kumar,Partner,Accel
00:10:00
Investments by Industry Year and Region|Arash Ferdowsi,Angel Investor,Arash Ferdowsi
00:10:00
Insights from Brad Boat of Capital Group's American Funds|Bradley J. Vogt,manager,capital Group
00:10:00
Accor CEO Sébastien Bazin on Strategic Acquisitions, Brand Expansions, and Future Vision | Sébastien Bazin, CEO , Accor SA.
00:10:00
Gene Sheridan, Co-Founder and CEO of Navitas (NVTS), discusses the impact of the CHIPS Act on the semiconductor industry on Worldwide Exchange.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
CEO Robert Cameron Advocates Prospect Generator Model for Commander Resources Ltd. | Robert Cameron, President & CEO of Commander Resources Ltd.
00:10:00
Navigating Market Volatility: Sunrun CEO Addresses Growth and Concerns | Mary Powell, CEO ,Sunrun Inc.
00:10:00
Interview with Forensics Expert David Brookman on Tucson Means Business
00:10:00
The preeminent team of experts driving your remarkable success today and beyond|Robert R. Lowther,President,The Denali Group

© 2026 Nehu